Le Lézard
Classified in: Science and technology, Business
Subjects: TNM, PER

Ex Libris Acquires Research Research Ltd., Industry Leader in the Coverage of Research Funding Opportunities, News, and Analysis


LONDON, Aug. 6, 2018 /PRNewswire/ -- Ex Libris®, a ProQuest company, is pleased to announce the acquisition of Research Research Limited (known as *Research). This acquisition is part of the ongoing strategic investment by Ex Libris aimed at providing a broad and deep offering for academic research stakeholders?scholars, research offices, and libraries.

Ex Libris, a ProQuest company

Founded in 1994, *Research offers broad coverage of funding opportunities and publishes authoritative news and analysis of research politics and funding that improve decision-making by research stakeholders. The company has an extensive customer base of over 250 institutions in the United Kingdom, continental Europe, Australia, and New Zealand. Many of these institutions already have a strong relationship with Ex Libris.

*Research products and expertise complement the Ex Libris research services offering, which includes the Esplorotm research services platform, Pivot® funding and collaboration solution, RefWorks® reference manager, and Primo® and Summon® discovery services. The complementary funding databases of *Research and Pivot will enable Ex Libris to provide the broadest global coverage of funding sources, insights, and collaborator discovery. Ex Libris will continue to develop enhancements for *Research and Pivot services to the benefit of new and existing customers.

Ex Libris President Bar Veinstein noted, "This acquisition is an important step in executing our strategy to broaden our academic-research offering. *Research is a perfect match for our research services solutions and will enable us to bring researchers, research offices, and libraries the world-class tools they need to collaborate better, connect to funding sponsors, and gain valuable exposure for their work."

William Cullerne Bown, founder and executive chairman of *Research, said, "Over the past 24 years, our publications and services have established an important role in the research community, helping researchers, administrators, and policymakers be more effective. Ex Libris was drawn to *Research because of our unrivaled understanding of the research world and our robust, loyal customer base. Being part of the Ex Libris and ProQuest family will help us go farther, faster."

Cullerne Bown, a leading authority on the relationship between academic knowledge and the shaping of public policy, will join ProQuest in the role of Research Principal. With his extensive experience, Cullerne Bown will help ProQuest and Ex Libris achieve an even deeper understanding of the research world and enhance offerings for university research offices.

For additional information about this acquisition, see the frequently asked questions.

About Research Research Ltd.

Research Research, known as *Research, helps scholars and institutions ensure that smart ideas do not go to waste. To achieve a thorough understanding of the funding landscape, leading universities depend on the coverage, accuracy, relevance, and reliability of the *Research Professional database of funding opportunities and our news and analysis services, which report on directions in research funding. Using these tools, scholars make better-informed decisions about whether to develop a proposal or not. *Research serves over 250 institutions in the United Kingdom, continental Europe, Australia, and New Zealand. For more information, see our website and join us on Twitter.

About Ex Libris

Ex Libris, a ProQuest company, is a leading global provider of cloud-based solutions for higher education. Offering SaaS solutions for the management and discovery of the full spectrum of library and scholarly materials, as well as mobile campus solutions driving student engagement and success, Ex Libris serves thousands of customers in 90 countries. For more information about Ex Libris, see our website and join us on Facebook, YouTube, LinkedIn, and Twitter.

SOURCE Ex Libris


These press releases may also interest you

at 09:17
The following issues have been halted by CIRO Company: Medicus Pharma Ltd. TSX-Venture Symbol: MDCX  All Issues: Yes Reason: Pending News Halt Time (ET): 9:09 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 09:17
Risk3sixty, a leading cybersecurity technology and consulting firm, announced today that it has been named a Pacesetter Award winner by the Atlanta Business Chronicle for a sixth consecutive year. The Pacesetter Awards celebrate the 100...

at 09:15
via IBN...

at 09:15
The Seattle Kraken today announced new multi-year agreements with TEGNA and Prime Video to offer more options for fans to watch their games throughout the Pacific Northwest....

at 09:15
Thirty Madison, the specialty telemedicine company operating Keeps, Cove, and Nurx, today announced a partnership with Talkspace, a  leading online behavioral health company, to expand comprehensive mental health offerings for more than half a...

at 09:15
RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today it has successfully closed its first seed funding round, raising $16.5 million to propel its mission to develop and...



News published on and distributed by: